Literature DB >> 21059009

Altered systolic left ventricular function in horses completing a long distance endurance race.

H Amory1, D-M Votion, A Fraipont, A G Goachet, C Robert, F Farnir, E Van Erck.   

Abstract

REASONS FOR PERFORMING STUDY: It is unknown whether or not exercise-induced cardiac fatigue (EICF), as demonstrated in human athletes performing long duration exercise, occurs in endurance horses.
OBJECTIVE: To examine the effects of a long distance endurance race on left ventricular systolic function in horses.
METHODS: Echocardiography was performed before, and after, a 2 or 3 star international endurance race (106-132 km) in 11 horses. Systolic (s) and diastolic (d) interventricular and left ventricular free wall thickness (IVS and LVFW, respectively), left ventricular, left atrial and aortic internal diameter (LVID, LA and Ao, respectively), fractional shortening (FS) and ejection fraction (EF) were measured by echocardiography. Heart rate (HR), peak flow velocity (Vmax), flow velocity integral (FVI), ejection time (ET), pre-ejection period (PEP), velocity of circumferential fibre shortening (Vcf), stroke volume (SV) and cardiac output (CO) were measured from aortic Doppler wave recordings.
RESULTS: After the race, LVIDd, Ao, LA, EF, FS, FVI, SV, ET and ET indexed for HR were significantly lower and IVSd, LVFWd, HR, PEP, PEP/ET and Vcf significantly higher as compared with prerace values. Pre- to post exercise changes in those parameters were not significantly correlated with changes in HR or in LVIDd.
CONCLUSIONS: Results suggest that EICF, with a decrease in left ventricular systolic function, could occur post exercise in horses performing long duration endurance races. However, a multanecus effect of altered preload and heart rate on the studied variables cannot be discounted.
© 2010 EVJ Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 21059009     DOI: 10.1111/j.2042-3306.2010.00253.x

Source DB:  PubMed          Journal:  Equine Vet J Suppl


  7 in total

1.  Assessment of cardiac variables using a new electrocardiography lead system in horses.

Authors:  Worakij Cherdchutham; Kanoklada Koomgun; Suchanan Singtoniwet; Napattra Wongsutthawart; Napass Nontakanun; Wipasitnee Wanmad; Soontaree Petchdee
Journal:  Vet World       Date:  2020-06-29

2.  Relationships between body dimensions, body weight, age, gender, breed and echocardiographic dimensions in young endurance horses.

Authors:  D S Trachsel; A Giraudet; D Maso; G Hervé; D D Hauri; E Barrey; C Robert
Journal:  BMC Vet Res       Date:  2016-10-10       Impact factor: 2.741

3.  Left Ventricular Function After Prolonged Exercise in Equine Endurance Athletes.

Authors:  M Flethøj; C C Schwarzwald; M M Haugaard; H Carstensen; J K Kanters; L H Olsen; R Buhl
Journal:  J Vet Intern Med       Date:  2016-06-15       Impact factor: 3.333

4.  Speed and Cardiac Recovery Variables Predict the Probability of Elimination in Equine Endurance Events.

Authors:  Mohamed Younes; Céline Robert; François Cottin; Eric Barrey
Journal:  PLoS One       Date:  2015-08-31       Impact factor: 3.240

5.  Effects of Age, Exercise Duration, and Test Conditions on Heart Rate Variability in Young Endurance Horses.

Authors:  Mohamed Younes; Céline Robert; Eric Barrey; François Cottin
Journal:  Front Physiol       Date:  2016-05-02       Impact factor: 4.566

6.  Prospective pre- and post-race evaluation of biochemical, electrophysiologic, and echocardiographic indices in 30 racing thoroughbred horses that received furosemide.

Authors:  Catherine T Gunther-Harrington; Rick Arthur; Krista Estell; Beatriz Martinez Lopez; Alexandra Sinnott; Eric Ontiveros; Anita Varga; Joshua A Stern
Journal:  BMC Vet Res       Date:  2018-01-18       Impact factor: 2.741

7.  Circulating Transcriptional Profile Modulation in Response to Metabolic Unbalance Due to Long-Term Exercise in Equine Athletes: A Pilot Study.

Authors:  Katia Cappelli; Samanta Mecocci; Stefano Capomaccio; Francesca Beccati; Andrea Rosario Palumbo; Alessia Tognoloni; Marco Pepe; Elisabetta Chiaradia
Journal:  Genes (Basel)       Date:  2021-12-09       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.